Third Rock Ventures — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches.
BiotechDigital HealthMedical DevicesCambridge, US
DAVID ARTHUR SCOTT(Executive Officer)WINSTON XIA YAN(Executive Officer)FENG ZHANG(Director)ANNIE HAZLEHURST(Director)
BoardKEITH CRANDELL(Director)DAVID R. WALT(Director)in
Board seatMark Angelino· per SEC Form D · $215M raise · filed Nov 2021
Co-investorsARCH Venture PartnersIllumina VenturesOno Venture Investment, Inc.TCG Crossover
Faction is a venture capital firm that invests in cryptocurrency and blockchain projects at the seed and series A stages, focusing on entrepreneurs building fundamental utility across the technology stack.
BiotechCrypto & Web3New York, US
Oren Harnevo(Executive Officer, Director)Ronald Bianchini, Jr.(Executive Officer, Director)Christina Calvaneso(Executive Officer)Brian Pozesky(Executive Officer)Jeff Fagel(Executive Officer)SAMANTHA SINGER(Executive Officer, Director)
Board seatDavid KaufmanAbbie Celniker· per SEC Form D · filed Dec 2023
Co-investorsAccelAdaverseAlephAxeleo CapitalBluebird VenturesBright Pixel Capital+36 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.